Safety of Continuing Single‐Agent Antithrombotic Therapy During Emergency Cholecystectomy for Acute Cholecystitis: An Overlap‐Weighted Propensity Score Analysis With the Hiroshima Surgical Study Group of Clinical Oncology ( HiSCO )
Journal of Hepato-Biliary-Pancreatic Sciences · 05.11.2026
DOI: 10.1002/jhbp.70212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 05.11.2026. Verfasst von Takeshi Tadokoro und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background/Purpose Optimal perioperative antithrombotic therapy (ATT) management during emergency cholecystectomy for acute cholecystitis remains controversial. We examined whether continuing single‐agent ATT is associated with hemorrhagic risk compared with no ATT.
Methods
This retrospective cohort study included 1018 patients (826 without ATT, 192 continued on single‐agent ATT) at seven institutions (2020–2023). Propensity score overlap weighting balanced 12 baseline covariates. The primary outcome was intraoperative blood loss > 100 mL; risk ratios and 95% confidence intervals were estimated via modified Poisson regression, with upper confidence bound compared against a pre‐specified risk ratio (1.5).
Results
The primary outcome occurred in 27.3% and 25.4% of the non‐ATT and continued‐ATT groups, respectively (risk ratio: 0.93, 95% confidence interval: 0.69–1.26). The upper bound of the confidence interval was within the pre‐specified margin. No significant differences were observed in perioperative bleeding complications or hospital stay. Secondary outcomes, sensitivity analyses, and drug‐specific subgroup analyses (including direct oral anticoagulants) yielded consistent results.
Conclusions
Continuing single‐agent ATT was comparable to no ATT regarding bleeding during cholecystectomy for acute cholecystitis. These findings suggest that emergency cholecystectomy can be performed without meaningful increases in hemorrhagic risk in patients for whom adequate preoperative ATT washout is not feasible.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
- Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.
- Department of Gastroenterological Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan.
- Department of Surgery, Chugoku Rosai Hospital, Kure, Japan.
- Department of Surgery, Onomichi General Hospital, Onomichi, Japan.
- Department of Surgery, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima, Japan.
ORCID-Profile: Takeshi Tadokoro, Tomoyuki Abe, Masateru Yamamoto, Naruhiko Honmyo, Seiichi Shimizu, Shintaro Kuroda, Hiroyuki Tahara, Masahiro Ohira, Tsuyoshi Kobayashi, Ko Oshita, Michinori Hamaoka, Masashi Inoue, Tomoyuki Akita, Hideki Ohdan
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Tadokoro, T., Abe, T., Yamamoto, M., Imaoka, Y., Honmyo, N., Nakano, R., Shimizu, S., Kuroda, S., Tahara, H., Ohira, M., Kobayashi, T., Hashimoto, M., Oshita, K., Sakai, H., Hamaoka, M., Tanimine, N., Inoue, M., Akita, T., Ohdan, H., & Hiroshima Surgical Study Group of Clinical Oncology (HiSCO) (2026). Safety of Continuing Single‐Agent Antithrombotic Therapy During Emergency Cholecystectomy for Acute Cholecystitis: An Overlap‐Weighted Propensity Score Analysis With the Hiroshima Surgical Study Group of Clinical Oncology ( HiSCO ). Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70212
Vancouver
Tadokoro T, Abe T, Yamamoto M, Imaoka Y, Honmyo N, Nakano R, et al. Safety of Continuing Single‐Agent Antithrombotic Therapy During Emergency Cholecystectomy for Acute Cholecystitis: An Overlap‐Weighted Propensity Score Analysis With the Hiroshima Surgical Study Group of Clinical Oncology ( HiSCO ). Journal of Hepato-Biliary-Pancreatic Sciences. 2026. doi:10.1002/jhbp.70212
BibTeX
@article{Tadokoro2026,
author = {Tadokoro, Takeshi and Abe, Tomoyuki and Yamamoto, Masateru and Imaoka, Yuki and Honmyo, Naruhiko and Nakano, Ryosuke and Shimizu, Seiichi and Kuroda, Shintaro and Tahara, Hiroyuki and Ohira, Masahiro and Kobayashi, Tsuyoshi and Hashimoto, Masakazu and Oshita, Ko and Sakai, Hiroshi and Hamaoka, Michinori and Tanimine, Naoki and Inoue, Masashi and Akita, Tomoyuki and Ohdan, Hideki and Hiroshima Surgical Study Group of Clinical Oncology (HiSCO), Hiroshima Surgical Study Group of Clinical Oncology (HiSCO)},
title = {Safety of Continuing Single‐Agent Antithrombotic Therapy During Emergency Cholecystectomy for Acute Cholecystitis: An Overlap‐Weighted Propensity Score Analysis With the Hiroshima Surgical Study Group of Clinical Oncology ( HiSCO )},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2026},
doi = {10.1002/jhbp.70212}
}
EUVIMED